This course is still available as a learning tool but has expired for CME credit.
Hyponatremia is the most common electrolyte imbalance in hospitalized patients that is often misdiagnosed or undiagnosed due to its nonspecific symptoms. Early diagnosis and adequate treatment are crucial to prevent increased morbidity and mortality. Recently, targeted therapies known as vaptans have become available. Physicians need to understand how to integrate the use of these agents with traditional methods of management. This CME activity is led by a group of experts discussing efficacy and safety data, risk assessment and early diagnosis, therapeutic targets, strategies for the critical care, as well as clinical decision making for the management of patients with hyponatremia.
Critical Care Specialists, Internists, cardiologists, nephrologists, emergency room physicians, hospitalists, and other clinicians who care for patients with hyponatremia and syndrome of inappropriate antidiuretic hormone secretion (SIADH).
Upon completion of this activity, participants will be able to:
- Develop and implement optimal strategies to improve your diagnosis and staging of hyponatremia.
- Evaluate clinical trial data for hyponatremia and SIADH science and therapeutic targets, including arginine vasopressin receptors.
- Develop personalized treatment strategies for the application of vasopressin receptor antagonists in patients with complex and difficult to treat hyponatremia.